Graftable
Biotechnology ResearchView the employees at
Graftable-
Sarah Ebmeier Founder and CEO at Graftable
-
Top 10%
-
Overview
Graftable is developing biomaterial therapeutics to promote natural regeneration after injury. Our technology is particularly beneficial for grafts of metabolically demanding tissues such as fat for face or breast reconstruction. Our mission is to make reconstruction and regeneration of damaged tissues more effective.